Bearing nsPVA Embolization for Uterine Artery Embolization (BETTER-UAE)

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

August 22, 2024

Primary Completion Date

April 30, 2025

Study Completion Date

October 31, 2025

Conditions
Uterine Fibroid
Interventions
DEVICE

Bearing nsPVA

Bearing nsPVA Embolization Particles are irregularly-shaped, biocompatible, hydrophilic, nonresorbable particles produced from polyvinyl alcohol. These embolization particles are intended to provide vascular occlusion or reduction of blood flow within target vessels upon selective placement through a variety of catheters. Bearing nsPVA Embolization Particles are used for the embolization of symptomatic (leiomyoma uteri) uterine fibroids.

Trial Locations (1)

Unknown

RECRUITING

The Alfred Health, Sydney

Sponsors
All Listed Sponsors
lead

Merit Medical Systems, Inc.

INDUSTRY

NCT06153667 - Bearing nsPVA Embolization for Uterine Artery Embolization (BETTER-UAE) | Biotech Hunter | Biotech Hunter